Axe Compute Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Axe Compute Inc.
- Former names
- Predictive Oncology Inc. Precision Therapeutics Inc. Skyline Medical Inc. BioDrain Medical, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 6199 — Finance Services
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Pittsburgh
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AGPU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001446159
- EIN
- 33-1007393
Board of directors
-
Charles Lee Nuzum Sr. · DirectorSince 2023
-
Christopher Miglino · Director · CEO and DirectorSince 2026
-
Clair Gregory St. Sr. · DirectorSince 2023
-
Daniel E. Handley · DirectorSince 2023
-
David Stewart Smith · DirectorSince 2023
-
Matthew Hawryluk · DirectorSince 2023
-
Nancy Chung-Welch · DirectorSince 2023
-
Raymond F. Vennare · Director · Chief Executive OfficerSince 2023
- Since 2025
-
Theodore Zhu · DirectorSince 2026
-
Veena Rao · DirectorSince 2023
Chief executives
Christopher Miglino
· CEO and Director
Since February 2026
Raymond F. Vennare
· CHIEF EXECUTIVE OFFICER
Until February 2026
· Former
Director election results
Annual meeting of November 25, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.8%
-
95.8%
Board connections
1 of this board's directors also sit on 5 other boards.
- via Shawn Matthews
- via Shawn Matthews
- via Shawn Matthews
- via Shawn Matthews
- via Shawn Matthews
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $98,325
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Theodore Zhu Director | Open-market purchase | +5,000 | $10.88 | $54,375 |
| Sep 8, 2026 | Theodore Zhu Director | Open-market purchase | +3,750 | $11.72 | $43,950 |
| Jul 1, 2026 | Daniel E. Handley Director | Grant or award | +1,716 | — | — |
| Jul 1, 2026 | Matthew Hawryluk Director | Grant or award | +1,716 | — | — |
| Jul 1, 2026 | Charles Lee Nuzum Sr. Director | Grant or award | +2,420 | — | — |
| Jul 1, 2026 | Clair Gregory St. Sr. Director | Grant or award | +2,420 | — | — |
| Jul 1, 2026 | Theodore Zhu Director | Grant or award | +2,420 | — | — |
| May 29, 2026 | Theodore Zhu Director | Grant or award | +11,250 | $6.61 | $74,363 |
| May 28, 2026 | Theodore Zhu Director | Grant or award | +3,750 | $6.61 | $24,788 |
| May 14, 2026 | Blacher Joshua Officer (Co-Chief Financial Officer) | Grant or award | +9,389 | — | — |
| Apr 20, 2026 | Theodore Zhu Director | Grant or award | +5,144 | — | — |
| Apr 20, 2026 | Charles Lee Nuzum Sr. Director | Grant or award | +14,082 | — | — |
| Apr 20, 2026 | Clair Gregory St. Sr. Director | Grant or award | +9,419 | — | — |
| Apr 20, 2026 | Matthew Hawryluk Director | Grant or award | +6,782 | — | — |
| Apr 20, 2026 | Daniel E. Handley Director | Grant or award | +5,663 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.